Genetic Testing Services Market Report 2026

The genetic testing services market size has grown rapidly in recent years. It will grow from $21.36 billion in 2025 to $23.75 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to consumer interest in ancestry testing, availability of sequencing technologies, early adoption in academic research, growing awareness of inherited diseases, laboratory service expansion.

The genetic testing services market size is expected to see strong growth in the next few years. It will grow to $34.09 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration of genomics into routine care, demand for personalized health insights, expansion of digital health platforms, regulatory clarity for testing services, growth of preventive medicine. Major trends in the forecast period include growth of direct-to-consumer genetic testing services, increasing demand for disease risk assessment services, expansion of prenatal and newborn genetic services, rising adoption of ancestry and genealogy testing, increased use of genetic counseling services.

The growing prevalence of genetic disorders is anticipated to drive the expansion of the genetic testing services market in the coming years. Genetic disorders are conditions that arise from abnormalities in an individual’s DNA and can result in physical or developmental impairments. The rise in genetic disorder cases is attributed to factors such as greater awareness, advancements in diagnostic technologies, wider adoption of genetic screening programs, and the increasing incidence of consanguineous marriages in certain populations. Genetic testing services are being increasingly used for the diagnosis, prognosis, and treatment planning of individuals with genetic conditions, supporting personalized healthcare and informed family planning based on genetic profiles. For example, in February 2023, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations focused on global public health, reported that congenital conditions cause an estimated 240,000 newborn deaths worldwide within the first 28 days of life each year. Additionally, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, approximately 6,000 babies are born with Down syndrome annually in the United States, representing about 1 in every 700 births. Consequently, the rising prevalence of genetic disorders is fueling growth in the genetic testing services market.

Key players in the genetic testing services market are concentrating on the development of advanced technologies, such as cancer screening tests, to improve diagnostic accuracy, broaden testing portfolios, and enhance patient outcomes. Cancer screening tests are routine, periodic examinations performed on individuals without symptoms to detect cancer at an early stage. These tests are designed to identify cancer or precancerous changes before clinical symptoms appear, enabling more effective treatment interventions. For instance, in May 2025, Guardant Health, a US-based provider of precision oncology diagnostics, including blood-based liquid biopsies and genetic profiling, introduced the Guardant Hereditary Cancer test to expand its genetic testing services into hereditary cancer risk assessment and strengthen its oncology screening and prevention platform. The Guardant Health test offers a blood-based 82-gene hereditary cancer panel that can be combined with Guardant360 using the same sample, delivering results within 2-3 weeks to support efficient inherited cancer risk detection.

In February 2025, Tempus, a US-based company offering precision medicine solutions, AI-driven clinical insights, and oncology-focused genetic testing services, completed the acquisition of Ambry Genetics for an undisclosed value. Through this acquisition, Tempus intends to enhance its genetic testing capabilities by integrating Ambry’s hereditary disease testing services into its precision medicine platform, thereby strengthening its technological expertise and expanding its footprint in the clinical genetic diagnostics market. Ambry Genetics is a US-based provider of genetic testing services for hereditary cancer, cardiovascular diseases, pediatric conditions, and rare disorders, delivering comprehensive diagnostic solutions for both clinical and research use.

Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc, 23andMe Holding Co, Berry Genomics Co. Ltd, Pacific Biosciences of California Inc, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics.

North America was the largest region in the genetic testing services market in 2025. The regions covered in the genetic testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the genetic testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the genetic testing services market by increasing costs of imported sequencing reagents, testing kits, and laboratory equipment. Diagnostic service providers in developed regions are most affected due to reliance on imported consumables. These tariffs increase service costs by raising per-test expenses, equipment maintenance costs, and operational overheads, potentially limiting affordability and test volumes for preventive and clinical genetic screening. However, they support domestic laboratory capacity expansion by encouraging investment in local reagent sourcing, in-house testing capabilities, and regionally based genomic infrastructure.

The genetic testing services market research report is one of a series of new reports that provides genetic testing services market statistics, including genetic testing services industry global market size, regional shares, competitors with a genetic testing services market share, detailed genetic testing services market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing services industry. This genetic testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genetic testing services involve the examination of an individual’s DNA to detect variations or mutations that may indicate disease risk, ancestry, or other inherited characteristics. These services generally provide information on potential health conditions, ancestral background, and tailored recommendations based on genetic tendencies, supporting informed healthcare decisions and lifestyle modifications.

The key types of genetic testing services include predictive testing, carrier testing, prenatal testing, newborn screening, and other related services. Predictive testing is a medical or genetic assessment used to evaluate an individual’s probability of developing a specific condition or disease in the future. These services address conditions such as cancer, metabolic disorders, cardiovascular diseases, and others, and are utilized by a range of end users including diagnostic laboratories, hospitals and clinics, academic institutions and research centers, as well as other organizations.

The genetic testing services market consists of revenues earned by entities by providing services such as newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and presymptomatic testing, ancestry testing, nutrigenomics testing, and forensic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.